Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age

BACKGROUND: Recent studies have suggested a blunted immune response to messenger RNA vaccines in solid organ transplant (SOT) recipients. Given the paucity of data on adenovirus vector vaccines use in immunosuppressed SOT recipients, we sought to describe the safety and immunogenicity of the ChAdOx1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Richard, Starr, Neasa, Chan, Grace, Dempsey, Eimear, Heffernan, Emma, Newman, Ellen, O'Neill, James, Hannan, Margaret M., Lynch, Breda, Joyce, Emer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743281/
https://www.ncbi.nlm.nih.gov/pubmed/35090809
http://dx.doi.org/10.1016/j.healun.2022.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743281/
https://www.ncbi.nlm.nih.gov/pubmed/35090809
http://dx.doi.org/10.1016/j.healun.2022.01.005

Ejemplares similares